Hikma expands its agreement with AFT Pharmaceuticals for the commercialisation of injectable pain medication Combogesic® into the Saudi, Jordanian and Iraqi Markets family health Hikma expands its agreement with AFT Pharmaceuticals for the commercialisation of injectable pain medication Combogesic® into the Saudi, Jordanian and Iraqi Markets AETOSWire sarjatha 12 February، 2024 into the Saudi, Jordanian and Iraqi Markets Amman, Jordan Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, has...Read More